Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism.

Adrenal Cortex Neoplasms / complications Adrenocortical Adenoma / complications Aldosterone / metabolism Angiotensin II Type 1 Receptor Blockers / metabolism Autoantibodies / metabolism Female Humans Hyperaldosteronism / etiology Hypertension / etiology Male Pre-Eclampsia / etiology Pregnancy Receptor, Angiotensin, Type 1 / immunology

Journal

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
ISSN: 1439-4286
Titre abrégé: Horm Metab Res
Pays: Germany
ID NLM: 0177722

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 14 3 2020
medline: 7 4 2021
entrez: 14 3 2020
Statut: ppublish

Résumé

Primary aldosteronism (PA) is the most common form of endocrine hypertension. Agonistic autoantibodies against the angiotensin II type 1 receptor (AT

Identifiants

DOI: 10.1055/a-1120-8647 PMID: 32168525 PMC: PMC7837338
pubmed: 32168525
doi: 10.1055/a-1120-8647
pmc: PMC7837338
doi:

Substances chimiques

Angiotensin II Type 1 Receptor Blockers 0
Autoantibodies 0
Receptor, Angiotensin, Type 1 0
Aldosterone 4964P6T9RB

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

379-385

Subventions

Organisme : grant agreement No. 694913
ID : The European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme
Organisme : Projektnummer: 314061271-TRR 205
ID : The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Références

Hypertension. 2007 Mar;49(3):612-7
pubmed: 17210828
Hypertension. 2019 Oct;74(4):784-792
pubmed: 31476909
J Am Coll Cardiol. 2014 Dec 30;64(25):2805-6
pubmed: 25541135
Nat Med. 2008 Aug;14(8):855-62
pubmed: 18660815
J Clin Med. 2019 Oct 04;8(10):
pubmed: 31590294
J Clin Invest. 1999 Apr;103(7):945-52
pubmed: 10194466
Transpl Int. 2014 Oct;27(10):1029-38
pubmed: 24909812
Biochem Pharmacol. 2019 Dec;170:113647
pubmed: 31585071
J Am Soc Hypertens. 2015 Jan;9(1):15-20
pubmed: 25537460
Front Biosci (Landmark Ed). 2019 Jun 1;24:1462-1476
pubmed: 31136991
Kidney Int. 2019 Jul;96(1):189-201
pubmed: 31005275
Am J Transplant. 2013 Oct;13(10):2577-89
pubmed: 23941128
Mol Neurodegener. 2014 Nov 15;9:49
pubmed: 25398321
Hypertension. 2013 Aug;62(2):331-6
pubmed: 23753408
Endocr Rev. 2017 Dec 1;38(6):516-537
pubmed: 28973103
Front Endocrinol (Lausanne). 2019 Aug 06;10:519
pubmed: 31447777
J Clin Endocrinol Metab. 2013 Dec;98(12):4826-33
pubmed: 24057288
Nephrology (Carlton). 2015 Mar;20 Suppl 1:10-2
pubmed: 25807851
Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699
pubmed: 28576687
J Am Coll Cardiol. 2017 Apr 11;69(14):1811-1820
pubmed: 28385310
J Am Coll Cardiol. 2006 Dec 5;48(11):2293-300
pubmed: 17161262
Transplantation. 2010 Dec 27;90(12):1473-7
pubmed: 21030904
Trends Mol Med. 2011 Mar;17(3):126-39
pubmed: 21183406
Circulation. 2003 Apr 1;107(12):1632-9
pubmed: 12668498
Pediatr Transplant. 2015 Aug;19(5):499-503
pubmed: 26058970
J Clin Hypertens (Greenwich). 2018 Sep;20(9):1313-1318
pubmed: 30058103
Hypertension. 2011 Jul;58(1):77-84
pubmed: 21576625
Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5274-5
pubmed: 23412332
J Clin Endocrinol Metab. 1978 Nov;47(5):938-43
pubmed: 400738
PLoS One. 2013 Apr 02;8(4):e60726
pubmed: 23589757
Front Immunol. 2017 May 31;8:603
pubmed: 28620373
Hypertension. 2017 Nov;70(5):875-881
pubmed: 28974569
Pharmacol Res. 2017 Nov;125(Pt A):14-20
pubmed: 28511989
J Hypertens. 2008 Aug;26(8):1629-35
pubmed: 18622242
Semin Immunopathol. 2014 May;36(3):351-63
pubmed: 24777744
J Am Coll Cardiol. 2011 Jan 18;57(3):356-65
pubmed: 21232674
Kidney Int. 2016 Aug;90(2):280-288
pubmed: 27188505
Mol Cell. 2006 Dec 8;24(5):643-652
pubmed: 17157248
Hypertension. 2010 Feb;55(2):386-93
pubmed: 19996068
Hypertension. 2018 Apr;71(4):563-565
pubmed: 29483226
Circulation. 2004 Sep 21;110(12):1612-9
pubmed: 15381659
Hypertension. 2019 Oct;74(4):793-799
pubmed: 31476908
J Hypertens. 2000 Jul;18(7):945-53
pubmed: 10930193
Ann Rheum Dis. 2011 Mar;70(3):530-6
pubmed: 21081526
Hypertension. 2002 Dec;40(6):892-6
pubmed: 12468575
Am J Transplant. 2013 Oct;13(10):2567-76
pubmed: 23919486
Cardiology. 2015;131(3):149-50
pubmed: 25926265
Hypertension. 2015 Oct;66(4):830-5
pubmed: 26259590
Nature. 2009 May 21;459(7245):356-63
pubmed: 19458711
Sci Rep. 2017 Oct 16;7(1):13293
pubmed: 29038523
N Engl J Med. 2005 Feb 10;352(6):558-69
pubmed: 15703421
Cardiovasc Diagn Ther. 2012 Mar;2(1):56-62
pubmed: 24282697
Am J Hypertens. 2005 Sep;18(9 Pt 2):134S-141S
pubmed: 16125050
J Clin Endocrinol Metab. 2014 May;99(5):1790-7
pubmed: 24552217
J Hypertens. 2010 Apr;28(4):834-41
pubmed: 20139770
Hypertension. 2013 Feb;61(2):526-33
pubmed: 23248149
Hypertension. 2007 Nov;50(5):911-8
pubmed: 17893375

Auteurs

Lucie S Meyer (LS)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Germany.

Siyuan Gong (S)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Germany.

Martin Reincke (M)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Germany.

Tracy Ann Williams (TA)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Germany.
Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies endocriniennes › Tumeurs des glandes endocrines › Tumeurs de la surrénale › Tumeurs corticosurrénaliennes › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Maladies endocriniennes › Tumeurs des glandes endocrines › Tumeurs de la surrénale › Tumeurs corticosurrénaliennes › Adénome corticosurrénalien › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Hormones corticosurrénaliennes › Hydroxycorticostéroïdes › 11-Hydroxycorticostéroïdes › Aldostérone › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antagonistes des récepteurs aux angiotensines › Antagonistes du récepteur de type 1 de l'angiotensine-II › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Autoanticorps › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Maladies endocriniennes › Maladies des surrénales › Hypercorticisme › Hyperaldostéronisme › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Hypertension artérielle › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Maladies urogénitales › Maladies de l'appareil urogénital féminin et complications de la grossesse › Complications de la grossesse › Pré-éclampsie › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › Angiotensin II Type 1 Receptor Autoantibodies...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteurs aux angiotensines › Récepteur de type 1 à l'angiotensine-II › Angiotensin II Type 1 Receptor Autoantibodies...